Article Sidebar

pdf
Date Published: 25/06/2025
Abstract Views: 98
Views pdf: 45
DOI: https://doi.org/10.51298/vmj.v551i2.14572
Issue
Vol. 551 No. 2 (2025)
Section
Các bài báo
How to Cite
Nghiêm Trung, D., Đặng Thị Việt, H., Vũ Công, M., & Nguyễn Trung, H. (2025). INITIAL ASSESSMENT OF BIOPSY RESULTS IN PATIENTS WITH PROSTATE HYPERPLASIA WITH INCREASED TOTAL PROSTATE SPECIFIC ANTIGEN AT BACH MAI HOSPITAL. Vietnam Medical Journal, 551(2). https://doi.org/10.51298/vmj.v551i2.14572

INITIAL ASSESSMENT OF BIOPSY RESULTS IN PATIENTS WITH PROSTATE HYPERPLASIA WITH INCREASED TOTAL PROSTATE SPECIFIC ANTIGEN AT BACH MAI HOSPITAL

Dũng Nghiêm Trung, Hà Đặng Thị Việt, Minh Vũ Công, Hiếu Nguyễn Trung

Main Article Content

Abstract

Objective: According to EAU 2019, prostate biopsy under transrectal ultrasound (TRUS) guidance is a crucial technique for early detection and is considered the gold standard for diagnosing prostate cancer. Therefore, to evaluate the results of prostate biopsy and explore the relationship between biopsy outcomes and other factors, we conducted this study. Research Objectives: To assess biopsy results and compare them with relevant factors at Bach Mai Hospital. Subjects and Research Methods: A cross-sectional descriptive study was conducted on 105 patients with benign prostatic hyperplasia (BPH) with total PSA > 4 ng/ml, who were indicated for prostate biopsy from July 2022 to March 2025. Results: The average age was 71.38 ± 7.26 years, with the oldest being 87 years and the youngest 55 years. The majority of patients were aged between 61-80 years. The cancer detection rate in this study was 55.2%. There was a statistically significant correlation between total PSA levels, MRI lesion classification according to PIRADS, and the location of prostate lesions with biopsy results. Conclusion: Prostate biopsy is recommended for individuals with: (1) Total PSA > 10 ng/ml or free PSA/total PSA ratio < 0.25 in patients with total PSA < 10 ng/ml, (2) MRI-identified lesions classified as PIRADS IV or higher, (3) Lesions located in the peripheral zone or involving both the transition and peripheral zones of the prostate

Article Details

Keywords

Benign prostatic hyperplasia, prostate cancer, prostate biopsy, total PSA

References

1. J. F. e. al, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012," Int J Cancer, pp. 359-386, 2015.
2. G. E. K. e. a. Patrick R. A, "Ascertainment of Veterans With Metastatic Prostate Cancer in Electronic Health Records: Demonstrating the Case for Natural Language Processing.," JCO clinical cancer informatics 5, pp. 1005-1014, 2021.
3. N. Mottet, "EAU – ESTRO – SIOG Guidelines on Prostate Cancer," European Association of Urology, 2019.
4. V. T. Kiên, "Nghiên cứu ứng dụng phương pháp sinh thiết tuyến tiền liệt 12 mẫu dưới hướng dẫn của siêu âm qua trực tràng trong chẩn đoán ung thư tuyến tiền liệt," Luận án tiến sỹ y học, 2020.
5. P. H. L. S. K. J. Shim HB, "Optimal site and number of biopsy cores according to prostate volume prostate cancer detection in Korea," Urology, vol. 69, pp. 902-906, 2007.
6. Nguyễn Trung Hiếu. Mai Hoàng Khoa, "đánh giá kết quả sinh thiết tuyến tiền liệt qua trực tràng dưới hướng dẫn siêu âm tại bệnh viện trường đại học y dược cần thơ và bệnh viện đa khoa trung ương cần thơ," tạp chí y dược học cần thơ, no. 74, 2024.
7. Lê Tuấn Khuê, "Khảo sát tỷ lệ f/t PSA khi PSA < 10ng/ml qua sinh thiết tuyến tiền liệt tại MEDIC," Tạp chí Y học TP. Hồ Chí Minh, vol. 16, no. 3, pp. 84-87, 2012.
8. Nguyễn Minh Châu, "kết quả bước đầu sinh thiết tuyến tiền liệt qua đường trực tràng dưới hướng dẫn siêu âm tại bệnh viện e," vietnam medical journal, vol. 540, no. 2, pp. 30-34, 2024.
9. S. D. R. T. e. a. Catalona W.J, "Measurement of prostate-specific antigen in serum as a screening test for prostate cancer," The New England Journal Medicine, p. 1156, 1991.
10. S. T. a. M. J.E, "Adenocarcinoma of the prostate," Campbell's Urology 6th, 1992.